|
1
|
Lacko M, Braakhuis BJ, Sturgis EM,
Boedeker CC, Suárez C, Rinaldo A, Ferlito A and Takes RP: Genetic
susceptibility to head and neck squamous cell carcinoma. Int J
Radiat Oncol Biol Phys. 89:38–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park MR, Kim SG, Cho IA, Oh D, Kang KR,
Lee SY, Moon SM, Cho SS, Yoon G, Kim CS, et al: Licochalcone-A
induces intrinsic and extrinsic apoptosis via ERK1/2 and p38
phosphorylation-mediated TRAIL expression in head and neck squamous
carcinoma FaDu cells. Food Chem Toxicol. 77:34–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vigneswaran N, Wu J, Song A, Annapragada A
and Zacharias W: Hypoxia-induced autophagic response is associated
with aggressive phenotype and elevated incidence of metastasis in
orthotopic immunocompetent murine models of head and neck squamous
cell carcinomas (HNSCC). Exp Mol Pathol. 90:215–225. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim JS, Oh D, Yim MJ, Park JJ, Kang KR,
Cho IA, Moon SM, Oh JS, You JS, Kim CS, et al: Berberine induces
FasL-related apoptosis through p38 activation in KB human oral
cancer cells. Oncol Rep. 33:1775–1782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kinghorn AD, Pan L, Fletcher JN and Chai
H: The relevance of higher plants in lead compound discovery
programs. J Nat Prod. 74:1539–1555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCarthy JV and Cotter TG: Cell shrinkage
and apoptosis: A role for potassium and sodium ion efflux. Cell
Death Differ. 4:756–770. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang M, Zhang HQ and Xue SB: Apoptosis of
HL-60 cells induced by Harringtonine: Membrane blebs, nucleus blebs
and chromatin condensation. Shi Yan Sheng Wu Xue Bao. 29:221–233.
1996.(In Chinese). PubMed/NCBI
|
|
8
|
Nagata S, Nagase H, Kawane K, Mukae N and
Fukuyama H: Degradation of chromosomal DNA during apoptosis. Cell
Death Differ. 10:108–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fesik SW: Promoting apoptosis as a
strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oh JS, Cho IA, Kang KR, You JS, Yu SJ, Lee
GJ, Seo YS, Kim CS, Kim K, Kim SG, et al: Biochanin-A antagonizes
the interleukin-1β-induced catabolic inflammation through the
modulation of NF-κB cellular signaling in primary rat chondrocytes.
Biochem Biophys Res Commun. 477:723–730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Booth NL, Piersen CE, Banuvar S, Geller
SE, Shulman LP and Farnsworth NR: Clinical studies of red clover
(Trifolium pratense) dietary supplements in menopause: A literature
review. Menopause. 13:251–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Q, Rimbach G, Moini H, Weber S and
Packer L: ESR and cell culture studies on free radical-scavenging
and antioxidant activities of isoflavonoids. Toxicology.
179:171–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ming X, Ding M, Zhai B, Xiao L, Piao T and
Liu M: Biochanin A inhibits lipopolysaccharide-induced inflammation
in human umbilical vein endothelial cells. Life Sci. 136:36–41.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu WY, Wu YY, Huang H, He C, Li WZ, Wang
HL, Chen HQ and Yin YY: Biochanin A attenuates LPS-induced
pro-inflammatory responses and inhibits the activation of the MAPK
pathway in BV2 microglial cells. Int J Mol Med. 35:391–398. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Puthli A, Tiwari R and Mishra KP:
Biochanin A enhances the radiotoxicity in colon tumor cells in
vitro. J Environ Pathol Toxicol Oncol. 32:189–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szliszka E, Czuba ZP, Mertas A, Paradysz A
and Krol W: The dietary isoflavone biochanin-A sensitizes prostate
cancer cells to TRAIL-induced apoptosis. Urol Oncol. 31:331–342.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su SJ, Chow NH, Kung ML, Hung TC and Chang
KL: Effects of soy isoflavones on apoptosis induction and G2-M
arrest in human hepatoma cells involvement of caspase-3 activation,
Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr
Cancer. 45:113–123. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JS, Park MR, Lee SY, Kim DK, Moon SM,
Kim CS, Cho SS, Yoon G, Im HJ, You JS, et al: Licochalcone A
induces apoptosis in KB human oral cancer cells via a
caspase-dependent FasL signaling pathway. Oncol Rep. 31:755–762.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Li HM, Zhou C, Li Q, Ma L, Zhang
Z, Sun Y, Wang L, Zhang X, Zhu B, et al: Non-benzoquinone
geldanamycin analogs trigger various forms of death in human breast
cancer cells. J Exp Clin Cancer Res. 35:1492016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SM: Human papilloma virus in oral
cancer. J Korean Assoc Oral Maxillofac Surg. 42:327–336. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seo YS, Yim MJ, Kim BH, Kang KR, Lee SY,
Oh JS, You JS, Kim SG, Yu SJ, Lee GJ, et al: Berberine-induced
anticancer activities in FaDu head and neck squamous cell carcinoma
cells. Oncol Rep. 34:3025–3034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Howren MB, Christensen AJ, Karnell L
Hynds, Van Liew JR and Funk GF: Influence of pretreatment social
support on health-related quality of life in head and neck cancer
survivors: Results from a prospective study. Head Neck. 35:779–787.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zafar A, Singh S and Naseem I: Cytotoxic
activity of soy phytoestrogen coumestrol against human breast
cancer MCF-7 cells: Insights into the molecular mechanism. Food
Chem Toxicol. 99:149–161. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee GA, Choi KC and Hwang KA: Kaempferol,
a phytoestrogen, suppressed triclosan-induced
epithelial-mesenchymal transition and metastatic-related behaviors
of MCF-7 breast cancer cells. Environ Toxicol Pharmacol. 49:48–57.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roh T, Kim SW, Moon SH and Nam MJ:
Genistein induces apoptosis by down-regulating thioredoxin-1 in
human hepatocellular carcinoma SNU-449 cells. Food Chem Toxicol.
97:127–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhardwaj V, Tadinada SM, Jain A, Sehdev V,
Daniels CK, Lai JC and Bhushan A: Biochanin A reduces pancreatic
cancer survival and progression. Anticancer Drugs. 25:296–302.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsuruo T, Naito M, Tomida A, Fujita N,
Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of
cancer: Drug resistance, apoptosis and survival signal. Cancer Sci.
94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. BioMed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stec R, Bodnar L, Smoter M, Mączewski M
and Szczylik C: Metastatic colorectal cancer in the elderly: An
overview of the systemic treatment modalities (Review). Oncol Lett.
2:3–11. 2011.PubMed/NCBI
|
|
30
|
Hsieh MJ, Chen JC, Yang WE, Chien SY, Chen
MK, Lo YS, Hsi YT, Chuang YC, Lin CC and Yang SF:
Dehydroandrographolide inhibits oral cancer cell migration and
invasion through NF-κB-, AP-1-, and SP-1-modulated matrix
metalloproteinase-2 inhibition. Biochem Pharmacol. 130:10–20. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang C, Jacobson K and Schaller MD: MAP
kinases and cell migration. J Cell Sci. 117:4619–4628. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kole L, Giri B, Manna SK, Pal B and Ghosh
S: Biochanin-A, an isoflavon, showed anti-proliferative and
anti-inflammatory activities through the inhibition of iNOS
expression, p38-MAPK and ATF-2 phosphorylation and blocking NF-κB
nuclear translocation. Eur J Pharmacol. 653:8–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsu HH, Liu CJ, Shen CY, Chen YJ, Chen LM,
Kuo WH, Lin YM, Chen RJ, Tsai CH, Tsai FJ, et al: p38α MAPK
mediates 17β-estradiol inhibition of MMP-2 and −9 expression and
cell migration in human lovo colon cancer cells. J Cell Physiol.
227:3648–3660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fromigué O, Hamidouche Z and Marie PJ:
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces
osteosarcoma cell invasion. J Biol Chem. 283:30549–30556. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bindhu OS, Ramadas K, Sebastian P and
Pillai MR: High expression levels of nuclear factor kappa B and
gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Head Neck. 28:916–925. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qin L, Liao L, Redmond A, Young L, Yuan Y,
Chen H, OMalley BW and Xu J: The AIB1 oncogene promotes breast
cancer metastasis by activation of PEA3-mediated matrix
metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol.
28:5937–5950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang H and Xue G: Major physiological
signaling pathways in the regulation of cell proliferation and
survival. Handb Exp Pharmacol. Feb 24–2017.https://doi.org/10.1007/164_2017_4 View Article : Google Scholar
|
|
38
|
Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J,
Wang L, Zhu ZF, Lu R and Yao Z: Growth differentiation factor 15
induces growth and metastasis of human liver cancer stem-like cells
via AKT/GSK-3β/β-catenin signaling. Oncotarget. 8:16972–16987.
2017.PubMed/NCBI
|
|
39
|
Tseng HS, Wang YF, Tzeng YM, Chen DR, Liao
YF, Chiu HY and Hsieh WT: Aloe-emodin enhances tamoxifen
cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer
cells. Am J Chin Med. 45:337–350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bahrami A, Khazaei M, Hasanzadeh M, Sales
S Shahid, Mashhad M Joudi, Farazestanian M, Sadeghnia HR, Rezayi M,
Maftouh M, Hassanian SM, et al: Therapeutic potential of targeting
PI3K/AKT pathway in treatment of colorectal cancer: Rational and
progress. J Cell Biochem. Feb 23–2017.(Epub ahead of print). doi:
10.1002/jcb.25950. View Article : Google Scholar
|
|
41
|
Lux MP, Fasching PA, Schrauder MG, Hein A,
Jud SM, Rauh C and Beckmann MW: The PI3K Pathway: Background and
treatment approaches. Breast Care (Basel). 11:398–404. 2016.
View Article : Google Scholar : PubMed/NCBI
|
